GT Biopharma, Inc. (GTBP) — Net Income

Annual figures by fiscal year, from SEC filings.

2010: -$3.00M2011: -$3.70M2012: -$5.17M2013: -$501.0K2014: -$23.49M2015: -$21.46M2016: $9.77M2017: -$144.17M2018: -$259.19M2019: -$38.65M2020: -$28.30M2021: -$58.01M2022: -$20.88M2023: -$7.60M2024: -$13.16M2025: -$28.35M-$28.35M
2010Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$28.35M-115.4%
2024-$13.16M-73.3%
2023-$7.60M+63.6%
2022-$20.88M+64.0%
2021-$58.01M-105.0%
2020-$28.30M+26.8%
2019-$38.65M+85.1%
2018-$259.19M-79.8%
2017-$144.17M-1576.0%
2016$9.77M+145.5%
2015-$21.46M+8.6%
2014-$23.49M-4588.4%
2013-$501.0K+90.3%
2012-$5.17M-39.8%
2011-$3.70M-23.5%
2010-$3.00M